Remdesivir Use and Hospital Length of Stay-The Paradox of a Clinical Trial vs Real-Life Use

被引：8
作者：
Baracco, Gio J. [1 ,2 ]
机构：
[1] Univ Miami, Miller Sch Med, Div Infect Dis, Miami, FL 33136 USA
[2] Miami VA Hlthcare Syst, Hosp Epidemiol & Occupat Hlth Serv, 1201 NW 16th St,Ste B1238, Miami, FL 33156 USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 07期
关键词：
D O I：
10.1001/jamanetworkopen.2021.16057
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 4 条
[1]  
Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]
[2]   Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19 [J].
Ohl, Michael E. ;
Miller, Donald R. ;
Lund, Brian C. ;
Kobayashi, Takaaki ;
Miell, Kelly Richardson ;
Beck, Brice F. ;
Alexander, Bruce ;
Crothers, Kristina ;
Sarrazin, Mary S. Vaughan .
JAMA NETWORK OPEN, 2021, 4 (07)
[3]  
U.S. Food and Drug Administration, FACT SHEET HEALTHC P
[4]  
VA Pharmacy Benefits Management Services, 2020, REMD EM US AUTH EUA
1